{"ticker": {"uuid": "07697fe2-0c91-44d9-88bb-4e1bf3b30e30", "symbol": "BHC", "name": "Bausch Health Companies Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "BHC4634780 Bond Profile \u2014 Key Metrics", "summary": "This article provides a detailed profile of the Bausch Health Companies Inc. 8.5% bond, maturing on January 31, 2027, under the identifier BHC4634780. It outlines key bond metrics such as the issue and maturity dates, outstanding amount, face value, and coupon rate, alongside a d", "url": "https://www.tradingview.com/symbols/FINRA-BHC4634780/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-13T23:09:43", "published_display": "13 Jul 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health\u2019s (BHC) Canadian Subsidiary Lists PrOKEDI Dosages in RAMQ Formulary", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/bausch-health-bhc-canadian-subsidiary-172132405.html", "source_name": "Insider Monkey", "published_at": "2026-07-12T17:21:32+00:00", "published_display": "12 Jul 2026 17:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health stock reflects a complex turnaround story for investors", "summary": "Bausch Health Companies Inc. (BHC) is currently undergoing a multi-year turnaround, focusing on restructuring, debt reduction, and strategic repositioning of its diversified healthcare businesses. The company, known for branded pharmaceuticals and eye-care products, faces the cha", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/bausch-health-stock-reflects-a-complex-turnaround-story-for-investors/69750675", "source_name": "ad-hoc-news.de", "published_at": "2026-07-12T05:10:48", "published_display": "12 Jul 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb launches AI-powered digital health platform", "summary": "Bausch + Lomb has introduced Orphia, an AI-powered digital health platform within its new Digital Health Services division. Developed with Hippocratic AI, Orphia aims to reduce administrative burdens for eye care providers, starting with pre-surgery cataract education. The platfo", "url": "https://www.investing.com/news/company-news/bausch--lomb-launches-aipowered-digital-health-platform-93CH-4783683", "source_name": "Investing.com", "published_at": "2026-07-09T12:40:56", "published_display": "09 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies updates its path in pharmaceuticals as investors watch broader sector trends", "summary": "Bausch Health Companies is continuing its turnaround strategy by focusing on branded pharmaceuticals and eye care, streamlining operations, and reducing its debt. The company emphasizes high-margin products in eye health, dermatology, and gastrointestinal treatments, while also w", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/bausch-health-companies-updates-its-path-in-pharmaceuticals-as-investors/69726739", "source_name": "AD HOC NEWS", "published_at": "2026-07-09T00:39:49", "published_display": "09 Jul 2026 00:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026", "summary": "Bausch Health Companies Inc. is scheduled to announce its second quarter 2026 financial results on July 29, 2026. The company will also host a conference call and webcast to discuss these results, providing an opportunity for investors and analysts to gain insights into its perfo", "url": "https://www.moomoo.com/news/post/72581951/bausch-health-to-announce-second-quarter-2026-results-on-july", "source_name": "Moomoo", "published_at": "2026-07-08T00:39:49", "published_display": "08 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc.", "summary": "Bausch Health Companies Inc. shares were trading up $0.07 at $6.90. The company is scheduled to release its second-quarter 2026 financial results after market close on Wednesday, July 29.", "url": "https://www.baystreet.ca/stocksinplayarticles/47494/Stocks-in-Play-Bausch-Health-Companies-Inc", "source_name": "Baystreet.ca", "published_at": "2026-07-07T14:12:51", "published_display": "07 Jul 2026 14:12", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BHC Stock Price Prediction 2025-2026 | Bausch Health Companies Inc Forecast", "summary": "24/7 Wall St. has issued a \"BUY\" rating for Bausch Health Companies Inc (BHC), projecting a target price of $6.81 within the next 12 months, representing a 38.73% upside from its current price of $4.91. The forecast includes an optimistic scenario of $7.63 and a conservative scen", "url": "https://247wallst.com/companies/BHC/price-prediction/", "source_name": "24/7 Wall St.", "published_at": "2026-07-07T13:10:48", "published_display": "07 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health plans July 29 call for Q2 results and business update", "summary": "Bausch Health (NYSE: BHC) is scheduled to release its second-quarter 2026 financial results after market close on Wednesday, July 29, 2026. The company will also host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update, wi", "url": "https://www.stocktitan.net/news/BHC/bausch-health-to-announce-second-quarter-2026-results-on-july-29-kflcpy7akxzp.html", "source_name": "Stock Titan", "published_at": "2026-07-07T11:09:50", "published_display": "07 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qu\u00e9bec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia", "summary": "Qu\u00e9bec has become the first province to list PrOKEDI\u00ae (extended-release injectable suspension of risperidone) on its public drug reimbursement formulary for the treatment of schizophrenia in adults, effective June 25th, 2026. This decision, announced by Bausch Health, Canada Inc.", "url": "https://ca.finance.yahoo.com/news/qu-bec-first-province-list-110000426.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-06T10:59:44", "published_display": "06 Jul 2026 10:59", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health (BHC) director granted RSUs in lieu of cash fees", "summary": "Bausch Health Companies Inc. director Amy B. Wechsler received 1,394 Restricted Share Units (RSUs) valued at $4.93 per share, instead of cash compensation for her board service for the quarter ending June 30, 2026. This transaction increased her direct holdings to 314,979 common ", "url": "https://www.stocktitan.net/sec-filings/BHC/form-4-bausch-health-companies-inc-insider-trading-activity-2ac5124d90b7.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:09:45", "published_display": "02 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health (NYSE: BHC) director granted 6,845 RSUs as board compensation", "summary": "Bausch Health Companies Inc. director Sandra Leung was granted 6,845 Restricted Share Units (RSUs) as compensation for her board service, valued at $4.93 per share, for the quarter ending June 30, 2026. This RSU grant is a routine, compensation-related award and not an open-marke", "url": "https://www.stocktitan.net/sec-filings/BHC/form-4-bausch-health-companies-inc-insider-trading-activity-0f2545a5278a.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:09:45", "published_display": "02 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health (NYSE: BHC) director John Paulson granted 12,677 RSUs as board pay", "summary": "Bausch Health Companies Inc. director John Paulson was granted 12,677 Restricted Share Units (RSUs) as compensation for his board service for the quarter ending June 30, 2026. Each RSU is valued at $4.93 per share and represents a contingent right to receive one common share. Fol", "url": "https://www.stocktitan.net/sec-filings/BHC/form-4-bausch-health-companies-inc-insider-trading-activity-0e9bb07a3dbf.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:09:45", "published_display": "02 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. Announces Resignation of Michael Goettler from Director Role, Effective June 30, 2026", "summary": "Bausch Health Companies Inc. announced that Michael Goettler has resigned from its Board of Directors, effective June 30, 2026. This resignation is due to his appointment as President and Chief Executive Officer of Knoa Pharma LLC. The company clarified that his departure was not", "url": "https://www.marketscreener.com/news/bausch-health-companies-inc-announces-resignation-of-michael-goettler-from-director-role-effective-ce7f5fd3d880f62d", "source_name": "www.marketscreener.com", "published_at": "2026-07-02T10:12:31", "published_display": "02 Jul 2026 10:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Michael Goettler Resigns from Bausch Health's Board of Directors", "summary": "Michael Goettler has resigned from the Board of Directors of Bausch Health Companies Inc., effective June 30, 2026. This resignation is due to his new appointment as President and Chief Executive Officer of Knoa Pharma LLC. Bausch Health expressed gratitude for his service, notin", "url": "https://www.prnewswire.com/news-releases/michael-goettler-resigns-from-bausch-healths-board-of-directors-302816240.html", "source_name": "PR Newswire", "published_at": "2026-07-01T20:40:24", "published_display": "01 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health board loses Goettler as he takes Knoa Pharma CEO role", "summary": "Bausch Health (NYSE:BHC) announced that director Michael Goettler resigned from its Board of Directors, effective June 30, 2026. This resignation follows his appointment as President and Chief Executive Officer of Knoa Pharma LLC. Bausch Health clarified that his departure was no", "url": "https://www.stocktitan.net/news/BHC/michael-goettler-resigns-from-bausch-health-s-board-of-d2ebt0myxt3s.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:40:24", "published_display": "01 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Michael Goettler exits Bausch Health (NYSE: BHC) board", "summary": "Bausch Health Companies Inc. announced that director Michael Goettler has resigned from its Board of Directors, effective June 30, 2026. This resignation is due to his appointment as President and Chief Executive Officer of Knoa Pharma LLC and was not related to any disagreements", "url": "https://www.stocktitan.net/sec-filings/BHC/8-k-bausch-health-companies-inc-reports-material-event-e163c2267adc.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:40:24", "published_display": "01 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb survey finds dry eye affects emotional health By Investing.com", "summary": "Bausch + Lomb's third annual State of Dry Eye survey reveals that dry eye symptoms significantly impact patients' emotional health and well-being, not just physical comfort. The survey found that a substantial percentage of sufferers experienced reduced self-confidence, emotional", "url": "https://ca.investing.com/news/stock-market-news/bausch--lomb-survey-finds-dry-eye-affects-emotional-health-93CH-4715808", "source_name": "Investing.com Canada", "published_at": "2026-07-01T11:40:24", "published_display": "01 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. Actuals & Estimates (MUN:BVF)", "summary": "This article provides an overview of Bausch Health Companies Inc. (BVF) on the Munich Stock Exchange, detailing its financial actuals and analyst estimates. It covers historical stock performance, future price forecasts, earnings, revenue, net income, employee count, and EBITDA. ", "url": "https://www.tradingview.com/symbols/MUN-BVF/forecast-actuals-and-estimates/?category=income_statement", "source_name": "TradingView", "published_at": "2026-06-27T05:09:19", "published_display": "27 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BVF Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast for Bausch Health Companies Inc. (BVF) stock, including analyst price targets, future earnings, and revenue estimates. It highlights that analysts have a max estimate of 7.91 EUR and a min estimate of 5.90 EUR for BVF's price. The company's last re", "url": "https://www.tradingview.com/symbols/DUS-BVF/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T18:11:06", "published_display": "26 Jun 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Bausch Health Companies Inc. \u2013 FWB:BVF", "summary": "This article focuses on the \"Price to earnings forward\" financial metric for Bausch Health Companies Inc., specifically its listing on the Frankfurt Stock Exchange (FWB:BVF). It appears to be a financial data snippet from TradingView, indicating no current trades and a closed mar", "url": "https://www.tradingview.com/symbols/FWB-BVF/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T12:10:22", "published_display": "26 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. Actuals & Estimates (NYSE:BHC)", "summary": "This article provides an overview of Bausch Health Companies Inc. (NYSE:BHC) financial actuals and estimates, including its current stock price, market capitalization, and volatility. It details analyst forecasts for BHC's future price, past stock performance, and upcoming earnin", "url": "https://www.tradingview.com/symbols/NYSE-BHC/forecast-actuals-and-estimates/?category=income_statement", "source_name": "TradingView", "published_at": "2026-06-26T06:10:22", "published_display": "26 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. Actuals & Estimates (BOATS:BHC)", "summary": "This article provides an overview of Bausch Health Companies Inc. (BHC) financials, including actuals and analyst estimates for its income statement, balance sheet, and cash flow. It details past earnings and revenue figures, upcoming earnings dates, and analyst price targets, no", "url": "https://www.tradingview.com/symbols/BOATS-BHC/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T00:10:22", "published_display": "26 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. Actuals & Estimates (LSX:A2JQ1X)", "summary": "This article provides an overview of Bausch Health Companies Inc. (A2JQ1X) stock performance, financial actuals, and analyst estimates. It includes current stock price, historical highs and lows, market capitalization, volatility, and details on recent earnings and revenue. The c", "url": "https://www.tradingview.com/symbols/LSX-A2JQ1X/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T00:09:59", "published_display": "26 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health stock hits 52-week low at 4.91 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQc2tXMHZUbmwtbnNlMlRDcTYzdTdwdGhacUtVNjRCQU1laExBb2dOaDk5R3RBZlpSUHdBS0MzcHFlR2piZHZiX3RIRThoY2daZlREMTBuV0FuWU9DeWlzVTIwLWxRTjB5MjVmUjg3NHFTN1p3bnZRelZMT25vTHFVaHZQY2xWajVYb2dCNktQZjdTM0VJVDhCaTVtRERsLXNlMUlwN0xR?oc=5", "source_name": "Investing.com", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Care Roundup: Market Talk", "summary": "", "url": "https://finance.yahoo.com/m/8e4aac72-5c4b-3958-82c6-afff3826c20c/health-care-roundup%3A-market.html", "source_name": "The Wall Street Journal", "published_at": "2026-06-09T21:06:00+00:00", "published_display": "09 Jun 2026 21:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI\u00ae (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/bausch-health-canada-inc-pan-120000837.html", "source_name": "CNW Group", "published_at": "2026-06-09T12:00:00+00:00", "published_display": "09 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health: Invest In The Short-Term Bonds, Not The Stock (NYSE:BHC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPdDFFc0stSGdzR2JSYllveWRSRDlZMENrQ05zQW15Vnp0WWJUb2RQWDZsNU9kWG4xYk9ScS1IX0JmNHNKVmNSdEFjbW9BV0JmMFpUZTZXZGwtUFhaUnc0cG4tbFdyR2JOekhReEFPVzJFcWw3U0ZDbDVZSGNVWUlDNVFoMnBzRllTbG05YXJKMTdpOFhDUjIzalUxTU5BZVJj?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxORWdub1ZvQi1TZkVfcXZqdTR0WGlKUVRuNkx4TTUzaXZ3RW5hSkppVlJlcDBvUHNxVVNicnFWUFFEaDNVVnZqYnpGV2ZoNlZlWGdHbU42RXNLLWktaFZNWkpiNTNEVnExYzFBZGxHQkFITkZNMklBZlN3cmp4aXVxLWNZck1WWXRkR3d5eg?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health, Solta Medical Say Thermage Brand Receives China Trademark Certification", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/bausch-health-solta-medical-thermage-204702738.html", "source_name": "MT Newswires", "published_at": "2026-05-28T20:47:02+00:00", "published_display": "28 May 2026 20:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage\u00ae in China", "summary": "", "url": "https://finance.yahoo.com/news/bausch-healths-aesthetic-business-solta-201500365.html", "source_name": "PR Newswire", "published_at": "2026-05-28T20:15:00+00:00", "published_display": "28 May 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/oligometastatic-disease-market-analysis-report-130200066.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T13:02:00+00:00", "published_display": "21 May 2026 13:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hear Bausch Health chiefs in live RBC healthcare chat May 20", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNZDZOc3h6ckJZQlhWbDBsUERTV25rVlF6czJtSzhKTzFrRE44dS1waDkwLV9fRlBfcFRxdi11d0xucHN6dmZYRl83ZXRQemtMdTJMSlZIbHVtbTZFNVItcXFVZEwzTlV2MHFoaUJLM1R0ejNsWlU2NFZhdmFueG8wb3dyMFJZWjFRYkNpeExxZTJ1RVpaM2pkbDlLelVuYkdaUWpvRFI3OF82THo2WnJnbHNoaHAyT0lC?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health (BHC) Q1 2026 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOU3FuT2szV2pVdkZpdmg0T1JLV2RFM1YxTGVLWWRGNnV4WWhKOWpBaUE4dDBvZkpJTFRSM2ZqdjVlX09jMnFVQnRDVWNfUkxoUDBiaElkUktaS3ZRd0JKRUJESkF2cUcxWmtIRVQ3dExQUi1NNnc2bzBuMXlDZnFRcWROZ1g3dVhZRVRva1UxRXQ2THc3S3RaRmw4enR2bXQwclVLMzFFNA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health (BHC) Lags Q1 Earnings Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOMVd2RVBPdjNmY3NGcXhTc2pXdXZlb0daVV9VWjNCZDZYeXo3QlU4YlR0WmRVWlNvQ0FPMDB5X2VyOUNqMGpGdkYyV19KOUEwcWNoZUhNVmE4SzdOUTRhQk9Tdk1iZTNqNnlUNnpGSUpCUmRvRVpGV01fVENGM2U2cGRrUy1oMFlGMEZObEU0aDh6aHZieUVnaDJB?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Compared to Estimates, Bausch (BHC) Q1 Earnings: A Look at Key Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOVmhYaXRvQzNiSU5HNzA4c3k5MTBNQ2VuUF9tQ2dfM19xWFZjX2IybE1QaTBGUVA1OXg5Z3lUNWxTMV9ka0NBUjRreWlhb0RIS2l0SEZPY3UxaFNuNjRCbDZnRXJueF9fMEpGQmtrUHZ5NEtBSlc4S2N4MVVPTXNqRmk3VXN0Q3BHYW5wYWE3NkZLY3Z6Q1VtVmlFZndjQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. (BHC): Billionaire Howard Marks Likes This Pharma Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPbHJXVDlUWnlQMVF6bWdOaE83dV9kZE8zczhob0dOM3RlTkdrYUhGNnRzbjdqZVVlRHhCWGQ1TWFjLWJKaGp4MElYSjUxX2dQWERYN2hGZDc4WW52NU5naDAtWExXM2hfdE10MEpVV0diZ2VpRzZ3aG1TMHlTY0NXQW90OGpKNTlqT0hPTUNRYm53Y05tT0hna3ZoRGpTQ1NPRmc?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health launches Biafine skincare emulsion online in U.S.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPQ0JkclJZNUZvaGRfSjZYZGxLeEVqa0E4ZVRHRHEzOVdwbW9ucl81UDhtXzJlbnlnUVRtSVlmWXdoZTB1WGJDaDhzNU1mdXNkZ3QxTzdBelNGTXRES1dZRndpel9jZkgtbXlNX3Z3OEZQMWxyQm05UC1YTXE1b3QxUEQ4WHFSUzIwNnladTBDTVdiTnlzQW1la2xVa1laVUh2VGhweUNvSmVsOG9xWUlsd1pXWV9fdzdrTmc?oc=5", "source_name": "Investing.com", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is the Options Market Predicting a Spike in Bausch Health Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOYXNrQmJpRUtBVDFaRDA0dzNSUVpzYXU4UlZLamQ0RFFXQXM4UnRPQktYSkF4X2h5UVZES3JUd2N2ajFhZnV5a1JRRmI5dWNZT0R6RURjNUsyVHlJNHZZZ0NIUWdBVHRlS09jQ05BZS0zZk4tQnZ6WjhDakdwZHFKams2NWtSb1ViNDhRN216U1Bmb2QyVEsxVHhFbmtLZEJTTTdSU3RFcw?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch (BHC) Down 15.2% Since Last Earnings Report: Can It Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQSXFDV1d1allKVkFWMk9xMkdEbUs1Nmd4dXNySGpEOEhCWVVOTThxbU1SVElCdzBVeDB5Z05NempqZzRYU0RfZVBZNmQ4a04yeTJHOTljOEUtWnJmZ0d1NmtIZ2lFSEo2ZUZJaE55WnZydzJudVdYZm10RDFMVXlYU2dBbGRfSGViQm5VWHBB?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Potential Bausch + Lomb Separation Reframes Bausch Health", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-04T08:00:00+00:00", "published_display": "04 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-01T08:00:00+00:00", "published_display": "01 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Bausch Health\u2019s Profit Return and 2026 Outlook Shift the Investment Case for BHC?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOOGZxZkxxc2hsVjRHZDZDRmZEXzlfQ25OWE5CQlk5U2I2N0ZUZ2RNUWJqeExac1NwME5LTmpMN01RWHRKQ3RhbmJDRGV0bG0xNXhpTERrWlBVYkFsLWVHN25SLUJ5T3pLRTUwZ1lTd3RYWXhwY0N2c1JLWlRoQVFsbEE5Z0Q?oc=5", "source_name": "Market source", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi\u2011Year Share Price Declines?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Bausch Health (BHC) Could Change Following Mixed 2025 Results And 2026 Outlook Guidance", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPc2pUQ19xSGRteS1kY2MtVklwTkhLT25JZlJOdFVCXzc0ZHphRThGZW1WRjdHdmk2SEhscWdqVVptdWYta25XSXEwbXl6SGliV3pzVEhvQ1hSaXVOOE9GZl9PVXJQUHhxZzFFQUdOVjAwWU1vSXhiNDZab1ZPbllVS19WOE9ueVJoRUQtY2w3dENnQQ?oc=5", "source_name": "Market source", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE9XaEtqYWpwalIyaUxWWUlpem9pSUJTWEo1UmtPel81VjUwaHRNMzFGVTVPQ1huQXp5dEJ0SFdJUzBwTzJjS2RYUFk3NTFUVm1WRk94REt6WG1CeURmOS1qZ0pCN3E2d3h0NW9JMXhZbF9SUmpFdWo4RHF3QWpGWDg?oc=5", "source_name": "Market source", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Curious about Bausch (BHC) Q4 Performance? Explore Wall Street Estimates for Key Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNYXRjZ3A5RHhGT0Nxd1YwVHFjVnlPOXBxTkNGbVVyMzh5MUJqczE0aTQ2R1FRTFp3N2lCNHJZc05FM1hGRkE4NzlGM2NpaG5BOG5kOWlsbVdNNHhFRi1uYzYybVpxcmZPdkdqbGt1LTRNdXBHR1hkSnY0SXpqeFhzSUpmaDQ2QQ?oc=5", "source_name": "Market source", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Has The Market Gone Too Far In Marking Down Bausch Health (BHC) Shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE9ZVklUWl94eGN6X2pSSkNUaHFLcmxyUHNDUXE4M2RCdE5meEN2c2RLOEMtZ0VXSUJHM1pKMjhZcWRUcnVrSGloUnNxUV84bVZYYkNPVFdOQW1rNDB1TEc2bno0bWJ0TFN1NE5wRWVlWTBmbDlZSEhnUTFoLTVudw?oc=5", "source_name": "Market source", "published_at": "2026-02-01T08:00:00+00:00", "published_display": "01 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health\u2019s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQcW1zTkxHZ2xXN09kaHkyQVdaVVBfNFk5aHdRR0RMc0RBRjZLSUJheEpjeklEdVpxbGY2dXpFSTExTnY1VzEwLTlYWGpWRkpkaFIwdTBDWDNKN2tXTS04SWV4T01jME5yU3VwakJCUUE0SEptWTU4OVhWaGZnNEd4ekgyOEdEOG9FU1NBalR0bFZHYUlJSHBXX2I5STBzczd3cDZuNE9GWHkzUmNzSmllRzhfMU4tSEVaNTltNnB1MnVMLWRQRk5RbXBJWWE?oc=5", "source_name": "The Motley Fool", "published_at": "2025-12-10T08:00:00+00:00", "published_display": "10 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxNdmk1RFFFWVNST0VNRHVUdlUtcF81SXpYMG9Qd002UUNCN1NxcW4tYWV3YWdvaDB3VlpuRXI2QXMzZ3dzOXlXZjZMTnJNVXlGWnhNZWJuRFhSc2x3NEZVN051YnpJMXQtOHFJOVZqTVV3dUNBWVZxekNHYVlaNGNSY2E1V3U2el93NzFENWx5Z2RUYzVkY0J2aGpjcTBaSzBDQmZ1S0s0ZWliUTBVbFdsaDV5bkVfaUhWb0hyNTBuVEpjRGdlS2UxX2o0UUVCMGxWUUZ1MUwxbG9pT3h6bExfcXVfSUJoRnBMeEI4VnJIUQ?oc=5", "source_name": "PR Newswire", "published_at": "2025-09-11T07:00:00+00:00", "published_display": "11 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Improved Revenues Required Before Bausch Health Companies Inc. (NYSE:BHC) Stock's 30% Jump Looks Justified", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-16T07:00:00+00:00", "published_display": "16 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgJBVV95cUxONlBwei1YN0hlbWNhTEdhZGkweGNSaUhfZmc1d1BxYjdiejV4bjRLaTlIMDIwUEpWQWtOYzlNZzNxS1ZXZHVmMjYybWwwTFlYaWRnaTVpMGFuQ0xtc1h1cHdocExmZWRQRnZPT1Nnd2RCX09jRGhXb0RvZmVxaHhyNkZZQUttUjdDdHd1eHBjc21FQjVNSWU4dGxXLWp1SWNBS2VXTVQzUmhWSFJOSnh2OEhCVjRYOWxtLWlxYUxTeThXTDc5ZVRYeGxRTFdxd0ZCSjAwZ0g1WnBWSnV3UlpKajFkMlJIZEtvc29GZ1lmcDBkMXlYRjFUbk5IOVB0VjhmNEtnWmFqbWhpNEdGNVE?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxNTUc2SHZsNGwyaURlQ0VzbXltMFZfcW9mbngyOG5wc3B4UzlSYm5tLWVveV9EZEZ4elhWd3NMQUxtV0hQa3g1ci16bXRkOW5zS2p5WGp4MlluODhESVNQc0lHZ1NKNEs5d1I1X19xZG9sU3J4WHZjbGduRkRvZndoSVotX0NIQ19PRk0wUmkwazB4Nl9XcEFCcXZJNkMwNE9sYzlocTdENlhsNDVyZUg3MUc2N3F2eVB6QTFhUFZjd01NQ2JNMWYySDVUMjc1Nmpic1M0dURVVlJiaHRwd3FseGhZZWtsSkFFVF9kQ1h1UVRRV2pHNEQ0dm1YejJUZ2NxTXI0dzBYYlVpTGpka0RzMEJmcEo0LXVYdU04?oc=5", "source_name": "PR Newswire", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "BHC4634780 Bond Profile \u2014 Key Metrics", "summary": "This article provides a detailed profile of the Bausch Health Companies Inc. 8.5% bond, maturing on January 31, 2027, under the identifier BHC4634780. It outlines key bond metrics such as the issue and maturity dates, outstanding amount, face value, and coupon rate, alongside a d", "url": "https://www.tradingview.com/symbols/FINRA-BHC4634780/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-13T23:09:43", "published_display": "13 Jul 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health\u2019s (BHC) Canadian Subsidiary Lists PrOKEDI Dosages in RAMQ Formulary", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/bausch-health-bhc-canadian-subsidiary-172132405.html", "source_name": "Insider Monkey", "published_at": "2026-07-12T17:21:32+00:00", "published_display": "12 Jul 2026 17:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health stock reflects a complex turnaround story for investors", "summary": "Bausch Health Companies Inc. (BHC) is currently undergoing a multi-year turnaround, focusing on restructuring, debt reduction, and strategic repositioning of its diversified healthcare businesses. The company, known for branded pharmaceuticals and eye-care products, faces the cha", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/bausch-health-stock-reflects-a-complex-turnaround-story-for-investors/69750675", "source_name": "ad-hoc-news.de", "published_at": "2026-07-12T05:10:48", "published_display": "12 Jul 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb launches AI-powered digital health platform", "summary": "Bausch + Lomb has introduced Orphia, an AI-powered digital health platform within its new Digital Health Services division. Developed with Hippocratic AI, Orphia aims to reduce administrative burdens for eye care providers, starting with pre-surgery cataract education. The platfo", "url": "https://www.investing.com/news/company-news/bausch--lomb-launches-aipowered-digital-health-platform-93CH-4783683", "source_name": "Investing.com", "published_at": "2026-07-09T12:40:56", "published_display": "09 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies updates its path in pharmaceuticals as investors watch broader sector trends", "summary": "Bausch Health Companies is continuing its turnaround strategy by focusing on branded pharmaceuticals and eye care, streamlining operations, and reducing its debt. The company emphasizes high-margin products in eye health, dermatology, and gastrointestinal treatments, while also w", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/bausch-health-companies-updates-its-path-in-pharmaceuticals-as-investors/69726739", "source_name": "AD HOC NEWS", "published_at": "2026-07-09T00:39:49", "published_display": "09 Jul 2026 00:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026", "summary": "Bausch Health Companies Inc. is scheduled to announce its second quarter 2026 financial results on July 29, 2026. The company will also host a conference call and webcast to discuss these results, providing an opportunity for investors and analysts to gain insights into its perfo", "url": "https://www.moomoo.com/news/post/72581951/bausch-health-to-announce-second-quarter-2026-results-on-july", "source_name": "Moomoo", "published_at": "2026-07-08T00:39:49", "published_display": "08 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc.", "summary": "Bausch Health Companies Inc. shares were trading up $0.07 at $6.90. The company is scheduled to release its second-quarter 2026 financial results after market close on Wednesday, July 29.", "url": "https://www.baystreet.ca/stocksinplayarticles/47494/Stocks-in-Play-Bausch-Health-Companies-Inc", "source_name": "Baystreet.ca", "published_at": "2026-07-07T14:12:51", "published_display": "07 Jul 2026 14:12", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BHC Stock Price Prediction 2025-2026 | Bausch Health Companies Inc Forecast", "summary": "24/7 Wall St. has issued a \"BUY\" rating for Bausch Health Companies Inc (BHC), projecting a target price of $6.81 within the next 12 months, representing a 38.73% upside from its current price of $4.91. The forecast includes an optimistic scenario of $7.63 and a conservative scen", "url": "https://247wallst.com/companies/BHC/price-prediction/", "source_name": "24/7 Wall St.", "published_at": "2026-07-07T13:10:48", "published_display": "07 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health plans July 29 call for Q2 results and business update", "summary": "Bausch Health (NYSE: BHC) is scheduled to release its second-quarter 2026 financial results after market close on Wednesday, July 29, 2026. The company will also host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update, wi", "url": "https://www.stocktitan.net/news/BHC/bausch-health-to-announce-second-quarter-2026-results-on-july-29-kflcpy7akxzp.html", "source_name": "Stock Titan", "published_at": "2026-07-07T11:09:50", "published_display": "07 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qu\u00e9bec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia", "summary": "Qu\u00e9bec has become the first province to list PrOKEDI\u00ae (extended-release injectable suspension of risperidone) on its public drug reimbursement formulary for the treatment of schizophrenia in adults, effective June 25th, 2026. This decision, announced by Bausch Health, Canada Inc.", "url": "https://ca.finance.yahoo.com/news/qu-bec-first-province-list-110000426.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-06T10:59:44", "published_display": "06 Jul 2026 10:59", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health (BHC) director granted RSUs in lieu of cash fees", "summary": "Bausch Health Companies Inc. director Amy B. Wechsler received 1,394 Restricted Share Units (RSUs) valued at $4.93 per share, instead of cash compensation for her board service for the quarter ending June 30, 2026. This transaction increased her direct holdings to 314,979 common ", "url": "https://www.stocktitan.net/sec-filings/BHC/form-4-bausch-health-companies-inc-insider-trading-activity-2ac5124d90b7.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:09:45", "published_display": "02 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health (NYSE: BHC) director granted 6,845 RSUs as board compensation", "summary": "Bausch Health Companies Inc. director Sandra Leung was granted 6,845 Restricted Share Units (RSUs) as compensation for her board service, valued at $4.93 per share, for the quarter ending June 30, 2026. This RSU grant is a routine, compensation-related award and not an open-marke", "url": "https://www.stocktitan.net/sec-filings/BHC/form-4-bausch-health-companies-inc-insider-trading-activity-0f2545a5278a.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:09:45", "published_display": "02 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health (NYSE: BHC) director John Paulson granted 12,677 RSUs as board pay", "summary": "Bausch Health Companies Inc. director John Paulson was granted 12,677 Restricted Share Units (RSUs) as compensation for his board service for the quarter ending June 30, 2026. Each RSU is valued at $4.93 per share and represents a contingent right to receive one common share. Fol", "url": "https://www.stocktitan.net/sec-filings/BHC/form-4-bausch-health-companies-inc-insider-trading-activity-0e9bb07a3dbf.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:09:45", "published_display": "02 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. Announces Resignation of Michael Goettler from Director Role, Effective June 30, 2026", "summary": "Bausch Health Companies Inc. announced that Michael Goettler has resigned from its Board of Directors, effective June 30, 2026. This resignation is due to his appointment as President and Chief Executive Officer of Knoa Pharma LLC. The company clarified that his departure was not", "url": "https://www.marketscreener.com/news/bausch-health-companies-inc-announces-resignation-of-michael-goettler-from-director-role-effective-ce7f5fd3d880f62d", "source_name": "www.marketscreener.com", "published_at": "2026-07-02T10:12:31", "published_display": "02 Jul 2026 10:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Michael Goettler Resigns from Bausch Health's Board of Directors", "summary": "Michael Goettler has resigned from the Board of Directors of Bausch Health Companies Inc., effective June 30, 2026. This resignation is due to his new appointment as President and Chief Executive Officer of Knoa Pharma LLC. Bausch Health expressed gratitude for his service, notin", "url": "https://www.prnewswire.com/news-releases/michael-goettler-resigns-from-bausch-healths-board-of-directors-302816240.html", "source_name": "PR Newswire", "published_at": "2026-07-01T20:40:24", "published_display": "01 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health board loses Goettler as he takes Knoa Pharma CEO role", "summary": "Bausch Health (NYSE:BHC) announced that director Michael Goettler resigned from its Board of Directors, effective June 30, 2026. This resignation follows his appointment as President and Chief Executive Officer of Knoa Pharma LLC. Bausch Health clarified that his departure was no", "url": "https://www.stocktitan.net/news/BHC/michael-goettler-resigns-from-bausch-health-s-board-of-d2ebt0myxt3s.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:40:24", "published_display": "01 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Michael Goettler exits Bausch Health (NYSE: BHC) board", "summary": "Bausch Health Companies Inc. announced that director Michael Goettler has resigned from its Board of Directors, effective June 30, 2026. This resignation is due to his appointment as President and Chief Executive Officer of Knoa Pharma LLC and was not related to any disagreements", "url": "https://www.stocktitan.net/sec-filings/BHC/8-k-bausch-health-companies-inc-reports-material-event-e163c2267adc.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:40:24", "published_display": "01 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch + Lomb survey finds dry eye affects emotional health By Investing.com", "summary": "Bausch + Lomb's third annual State of Dry Eye survey reveals that dry eye symptoms significantly impact patients' emotional health and well-being, not just physical comfort. The survey found that a substantial percentage of sufferers experienced reduced self-confidence, emotional", "url": "https://ca.investing.com/news/stock-market-news/bausch--lomb-survey-finds-dry-eye-affects-emotional-health-93CH-4715808", "source_name": "Investing.com Canada", "published_at": "2026-07-01T11:40:24", "published_display": "01 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. Actuals & Estimates (MUN:BVF)", "summary": "This article provides an overview of Bausch Health Companies Inc. (BVF) on the Munich Stock Exchange, detailing its financial actuals and analyst estimates. It covers historical stock performance, future price forecasts, earnings, revenue, net income, employee count, and EBITDA. ", "url": "https://www.tradingview.com/symbols/MUN-BVF/forecast-actuals-and-estimates/?category=income_statement", "source_name": "TradingView", "published_at": "2026-06-27T05:09:19", "published_display": "27 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BVF Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast for Bausch Health Companies Inc. (BVF) stock, including analyst price targets, future earnings, and revenue estimates. It highlights that analysts have a max estimate of 7.91 EUR and a min estimate of 5.90 EUR for BVF's price. The company's last re", "url": "https://www.tradingview.com/symbols/DUS-BVF/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T18:11:06", "published_display": "26 Jun 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Bausch Health Companies Inc. \u2013 FWB:BVF", "summary": "This article focuses on the \"Price to earnings forward\" financial metric for Bausch Health Companies Inc., specifically its listing on the Frankfurt Stock Exchange (FWB:BVF). It appears to be a financial data snippet from TradingView, indicating no current trades and a closed mar", "url": "https://www.tradingview.com/symbols/FWB-BVF/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T12:10:22", "published_display": "26 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. Actuals & Estimates (NYSE:BHC)", "summary": "This article provides an overview of Bausch Health Companies Inc. (NYSE:BHC) financial actuals and estimates, including its current stock price, market capitalization, and volatility. It details analyst forecasts for BHC's future price, past stock performance, and upcoming earnin", "url": "https://www.tradingview.com/symbols/NYSE-BHC/forecast-actuals-and-estimates/?category=income_statement", "source_name": "TradingView", "published_at": "2026-06-26T06:10:22", "published_display": "26 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. Actuals & Estimates (BOATS:BHC)", "summary": "This article provides an overview of Bausch Health Companies Inc. (BHC) financials, including actuals and analyst estimates for its income statement, balance sheet, and cash flow. It details past earnings and revenue figures, upcoming earnings dates, and analyst price targets, no", "url": "https://www.tradingview.com/symbols/BOATS-BHC/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T00:10:22", "published_display": "26 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. Actuals & Estimates (LSX:A2JQ1X)", "summary": "This article provides an overview of Bausch Health Companies Inc. (A2JQ1X) stock performance, financial actuals, and analyst estimates. It includes current stock price, historical highs and lows, market capitalization, volatility, and details on recent earnings and revenue. The c", "url": "https://www.tradingview.com/symbols/LSX-A2JQ1X/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T00:09:59", "published_display": "26 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health stock hits 52-week low at 4.91 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQc2tXMHZUbmwtbnNlMlRDcTYzdTdwdGhacUtVNjRCQU1laExBb2dOaDk5R3RBZlpSUHdBS0MzcHFlR2piZHZiX3RIRThoY2daZlREMTBuV0FuWU9DeWlzVTIwLWxRTjB5MjVmUjg3NHFTN1p3bnZRelZMT25vTHFVaHZQY2xWajVYb2dCNktQZjdTM0VJVDhCaTVtRERsLXNlMUlwN0xR?oc=5", "source_name": "Investing.com", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Care Roundup: Market Talk", "summary": "", "url": "https://finance.yahoo.com/m/8e4aac72-5c4b-3958-82c6-afff3826c20c/health-care-roundup%3A-market.html", "source_name": "The Wall Street Journal", "published_at": "2026-06-09T21:06:00+00:00", "published_display": "09 Jun 2026 21:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI\u00ae (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/bausch-health-canada-inc-pan-120000837.html", "source_name": "CNW Group", "published_at": "2026-06-09T12:00:00+00:00", "published_display": "09 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health: Invest In The Short-Term Bonds, Not The Stock (NYSE:BHC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPdDFFc0stSGdzR2JSYllveWRSRDlZMENrQ05zQW15Vnp0WWJUb2RQWDZsNU9kWG4xYk9ScS1IX0JmNHNKVmNSdEFjbW9BV0JmMFpUZTZXZGwtUFhaUnc0cG4tbFdyR2JOekhReEFPVzJFcWw3U0ZDbDVZSGNVWUlDNVFoMnBzRllTbG05YXJKMTdpOFhDUjIzalUxTU5BZVJj?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxORWdub1ZvQi1TZkVfcXZqdTR0WGlKUVRuNkx4TTUzaXZ3RW5hSkppVlJlcDBvUHNxVVNicnFWUFFEaDNVVnZqYnpGV2ZoNlZlWGdHbU42RXNLLWktaFZNWkpiNTNEVnExYzFBZGxHQkFITkZNMklBZlN3cmp4aXVxLWNZck1WWXRkR3d5eg?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health, Solta Medical Say Thermage Brand Receives China Trademark Certification", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/bausch-health-solta-medical-thermage-204702738.html", "source_name": "MT Newswires", "published_at": "2026-05-28T20:47:02+00:00", "published_display": "28 May 2026 20:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage\u00ae in China", "summary": "", "url": "https://finance.yahoo.com/news/bausch-healths-aesthetic-business-solta-201500365.html", "source_name": "PR Newswire", "published_at": "2026-05-28T20:15:00+00:00", "published_display": "28 May 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/oligometastatic-disease-market-analysis-report-130200066.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T13:02:00+00:00", "published_display": "21 May 2026 13:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hear Bausch Health chiefs in live RBC healthcare chat May 20", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNZDZOc3h6ckJZQlhWbDBsUERTV25rVlF6czJtSzhKTzFrRE44dS1waDkwLV9fRlBfcFRxdi11d0xucHN6dmZYRl83ZXRQemtMdTJMSlZIbHVtbTZFNVItcXFVZEwzTlV2MHFoaUJLM1R0ejNsWlU2NFZhdmFueG8wb3dyMFJZWjFRYkNpeExxZTJ1RVpaM2pkbDlLelVuYkdaUWpvRFI3OF82THo2WnJnbHNoaHAyT0lC?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health (BHC) Q1 2026 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOU3FuT2szV2pVdkZpdmg0T1JLV2RFM1YxTGVLWWRGNnV4WWhKOWpBaUE4dDBvZkpJTFRSM2ZqdjVlX09jMnFVQnRDVWNfUkxoUDBiaElkUktaS3ZRd0JKRUJESkF2cUcxWmtIRVQ3dExQUi1NNnc2bzBuMXlDZnFRcWROZ1g3dVhZRVRva1UxRXQ2THc3S3RaRmw4enR2bXQwclVLMzFFNA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health (BHC) Lags Q1 Earnings Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOMVd2RVBPdjNmY3NGcXhTc2pXdXZlb0daVV9VWjNCZDZYeXo3QlU4YlR0WmRVWlNvQ0FPMDB5X2VyOUNqMGpGdkYyV19KOUEwcWNoZUhNVmE4SzdOUTRhQk9Tdk1iZTNqNnlUNnpGSUpCUmRvRVpGV01fVENGM2U2cGRrUy1oMFlGMEZObEU0aDh6aHZieUVnaDJB?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Compared to Estimates, Bausch (BHC) Q1 Earnings: A Look at Key Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOVmhYaXRvQzNiSU5HNzA4c3k5MTBNQ2VuUF9tQ2dfM19xWFZjX2IybE1QaTBGUVA1OXg5Z3lUNWxTMV9ka0NBUjRreWlhb0RIS2l0SEZPY3UxaFNuNjRCbDZnRXJueF9fMEpGQmtrUHZ5NEtBSlc4S2N4MVVPTXNqRmk3VXN0Q3BHYW5wYWE3NkZLY3Z6Q1VtVmlFZndjQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Companies Inc. (BHC): Billionaire Howard Marks Likes This Pharma Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPbHJXVDlUWnlQMVF6bWdOaE83dV9kZE8zczhob0dOM3RlTkdrYUhGNnRzbjdqZVVlRHhCWGQ1TWFjLWJKaGp4MElYSjUxX2dQWERYN2hGZDc4WW52NU5naDAtWExXM2hfdE10MEpVV0diZ2VpRzZ3aG1TMHlTY0NXQW90OGpKNTlqT0hPTUNRYm53Y05tT0hna3ZoRGpTQ1NPRmc?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health launches Biafine skincare emulsion online in U.S.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPQ0JkclJZNUZvaGRfSjZYZGxLeEVqa0E4ZVRHRHEzOVdwbW9ucl81UDhtXzJlbnlnUVRtSVlmWXdoZTB1WGJDaDhzNU1mdXNkZ3QxTzdBelNGTXRES1dZRndpel9jZkgtbXlNX3Z3OEZQMWxyQm05UC1YTXE1b3QxUEQ4WHFSUzIwNnladTBDTVdiTnlzQW1la2xVa1laVUh2VGhweUNvSmVsOG9xWUlsd1pXWV9fdzdrTmc?oc=5", "source_name": "Investing.com", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is the Options Market Predicting a Spike in Bausch Health Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOYXNrQmJpRUtBVDFaRDA0dzNSUVpzYXU4UlZLamQ0RFFXQXM4UnRPQktYSkF4X2h5UVZES3JUd2N2ajFhZnV5a1JRRmI5dWNZT0R6RURjNUsyVHlJNHZZZ0NIUWdBVHRlS09jQ05BZS0zZk4tQnZ6WjhDakdwZHFKams2NWtSb1ViNDhRN216U1Bmb2QyVEsxVHhFbmtLZEJTTTdSU3RFcw?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch (BHC) Down 15.2% Since Last Earnings Report: Can It Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQSXFDV1d1allKVkFWMk9xMkdEbUs1Nmd4dXNySGpEOEhCWVVOTThxbU1SVElCdzBVeDB5Z05NempqZzRYU0RfZVBZNmQ4a04yeTJHOTljOEUtWnJmZ0d1NmtIZ2lFSEo2ZUZJaE55WnZydzJudVdYZm10RDFMVXlYU2dBbGRfSGViQm5VWHBB?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Potential Bausch + Lomb Separation Reframes Bausch Health", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-04T08:00:00+00:00", "published_display": "04 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-01T08:00:00+00:00", "published_display": "01 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Bausch Health\u2019s Profit Return and 2026 Outlook Shift the Investment Case for BHC?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOOGZxZkxxc2hsVjRHZDZDRmZEXzlfQ25OWE5CQlk5U2I2N0ZUZ2RNUWJqeExac1NwME5LTmpMN01RWHRKQ3RhbmJDRGV0bG0xNXhpTERrWlBVYkFsLWVHN25SLUJ5T3pLRTUwZ1lTd3RYWXhwY0N2c1JLWlRoQVFsbEE5Z0Q?oc=5", "source_name": "Market source", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi\u2011Year Share Price Declines?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNVUNJaHFJWlVESF9QcnRQdURkbHZpV1NhdW93Rmk2dTNMWTV6RTROZjBSS1c3T1ROWkZualA1U0V4cTdfOFdMVWUyemlmbUtRbU51QUprQVN5Wlk4b0NqRWxGVFl6aVE4c09WRlJqTmlPUDdHeUNDVFBpbU5sTURnNWJNT0R0RnRkSnFJcnVxbVp0OFFxUjIzc243aHJGa1AzSWhJek1lWXN0dE1NVWNuRkpOOUJGeGxhcmtJUEZhem9yaGdFTUdoUDdNZFp0LVRWRGN6Q2tPSUc4TzFZc2pBVjNYZnJrNmNlOWfSAe8BQVVfeXFMUF9LVUVsRlpvVTRxUFd1SnA3RXFsSGdzNDIzTEExZkVaaFF6OEdsaTBZSjBDMUI3UUpWWmFPaXItM0Jfd1RBYUtOenJGajlhaFlaSXh0Q2gtelhqdTNvQjc3TXhpZC1BOF94WE9VVF9BbXo1dk9ZbW9odUZ0eDVCTXVjb1VUaF9YVzhxU1Q4ZlpQeU1oVmwyd1p2dXZ3eFVmODFJNHJ5WGxod3lSWUdxZ1M4OGtFd1ZfcnNYd04yeWdMdHluaHRpMzhadnI2c1RONnZodXZXcG9WQk5LZ3pDQkZJSjZDaUxEOVhTQU55cHc?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Bausch Health (BHC) Could Change Following Mixed 2025 Results And 2026 Outlook Guidance", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPc2pUQ19xSGRteS1kY2MtVklwTkhLT25JZlJOdFVCXzc0ZHphRThGZW1WRjdHdmk2SEhscWdqVVptdWYta25XSXEwbXl6SGliV3pzVEhvQ1hSaXVOOE9GZl9PVXJQUHhxZzFFQUdOVjAwWU1vSXhiNDZab1ZPbllVS19WOE9ueVJoRUQtY2w3dENnQQ?oc=5", "source_name": "Market source", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE9XaEtqYWpwalIyaUxWWUlpem9pSUJTWEo1UmtPel81VjUwaHRNMzFGVTVPQ1huQXp5dEJ0SFdJUzBwTzJjS2RYUFk3NTFUVm1WRk94REt6WG1CeURmOS1qZ0pCN3E2d3h0NW9JMXhZbF9SUmpFdWo4RHF3QWpGWDg?oc=5", "source_name": "Market source", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Curious about Bausch (BHC) Q4 Performance? Explore Wall Street Estimates for Key Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNYXRjZ3A5RHhGT0Nxd1YwVHFjVnlPOXBxTkNGbVVyMzh5MUJqczE0aTQ2R1FRTFp3N2lCNHJZc05FM1hGRkE4NzlGM2NpaG5BOG5kOWlsbVdNNHhFRi1uYzYybVpxcmZPdkdqbGt1LTRNdXBHR1hkSnY0SXpqeFhzSUpmaDQ2QQ?oc=5", "source_name": "Market source", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Has The Market Gone Too Far In Marking Down Bausch Health (BHC) Shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE9ZVklUWl94eGN6X2pSSkNUaHFLcmxyUHNDUXE4M2RCdE5meEN2c2RLOEMtZ0VXSUJHM1pKMjhZcWRUcnVrSGloUnNxUV84bVZYYkNPVFdOQW1rNDB1TEc2bno0bWJ0TFN1NE5wRWVlWTBmbDlZSEhnUTFoLTVudw?oc=5", "source_name": "Market source", "published_at": "2026-02-01T08:00:00+00:00", "published_display": "01 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health\u2019s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQcW1zTkxHZ2xXN09kaHkyQVdaVVBfNFk5aHdRR0RMc0RBRjZLSUJheEpjeklEdVpxbGY2dXpFSTExTnY1VzEwLTlYWGpWRkpkaFIwdTBDWDNKN2tXTS04SWV4T01jME5yU3VwakJCUUE0SEptWTU4OVhWaGZnNEd4ekgyOEdEOG9FU1NBalR0bFZHYUlJSHBXX2I5STBzczd3cDZuNE9GWHkzUmNzSmllRzhfMU4tSEVaNTltNnB1MnVMLWRQRk5RbXBJWWE?oc=5", "source_name": "The Motley Fool", "published_at": "2025-12-10T08:00:00+00:00", "published_display": "10 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxNdmk1RFFFWVNST0VNRHVUdlUtcF81SXpYMG9Qd002UUNCN1NxcW4tYWV3YWdvaDB3VlpuRXI2QXMzZ3dzOXlXZjZMTnJNVXlGWnhNZWJuRFhSc2x3NEZVN051YnpJMXQtOHFJOVZqTVV3dUNBWVZxekNHYVlaNGNSY2E1V3U2el93NzFENWx5Z2RUYzVkY0J2aGpjcTBaSzBDQmZ1S0s0ZWliUTBVbFdsaDV5bkVfaUhWb0hyNTBuVEpjRGdlS2UxX2o0UUVCMGxWUUZ1MUwxbG9pT3h6bExfcXVfSUJoRnBMeEI4VnJIUQ?oc=5", "source_name": "PR Newswire", "published_at": "2025-09-11T07:00:00+00:00", "published_display": "11 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Improved Revenues Required Before Bausch Health Companies Inc. (NYSE:BHC) Stock's 30% Jump Looks Justified", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-16T07:00:00+00:00", "published_display": "16 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgJBVV95cUxONlBwei1YN0hlbWNhTEdhZGkweGNSaUhfZmc1d1BxYjdiejV4bjRLaTlIMDIwUEpWQWtOYzlNZzNxS1ZXZHVmMjYybWwwTFlYaWRnaTVpMGFuQ0xtc1h1cHdocExmZWRQRnZPT1Nnd2RCX09jRGhXb0RvZmVxaHhyNkZZQUttUjdDdHd1eHBjc21FQjVNSWU4dGxXLWp1SWNBS2VXTVQzUmhWSFJOSnh2OEhCVjRYOWxtLWlxYUxTeThXTDc5ZVRYeGxRTFdxd0ZCSjAwZ0g1WnBWSnV3UlpKajFkMlJIZEtvc29GZ1lmcDBkMXlYRjFUbk5IOVB0VjhmNEtnWmFqbWhpNEdGNVE?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxNTUc2SHZsNGwyaURlQ0VzbXltMFZfcW9mbngyOG5wc3B4UzlSYm5tLWVveV9EZEZ4elhWd3NMQUxtV0hQa3g1ci16bXRkOW5zS2p5WGp4MlluODhESVNQc0lHZ1NKNEs5d1I1X19xZG9sU3J4WHZjbGduRkRvZndoSVotX0NIQ19PRk0wUmkwazB4Nl9XcEFCcXZJNkMwNE9sYzlocTdENlhsNDVyZUg3MUc2N3F2eVB6QTFhUFZjd01NQ2JNMWYySDVUMjc1Nmpic1M0dURVVlJiaHRwd3FseGhZZWtsSkFFVF9kQ1h1UVRRV2pHNEQ0dm1YejJUZ2NxTXI0dzBYYlVpTGpka0RzMEJmcEo0LXVYdU04?oc=5", "source_name": "PR Newswire", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 84, "total_relevant": 55, "sentiment_summary": {"positive": 7, "negative": 3, "neutral": 45, "score": 52, "total": 55, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 15.55, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 9.9, "count": 18}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}], "positive_events": 7, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 4.78, "latest_week": "2026-07-10", "one_week_move": -2.4, "four_week_move": -5.5, "twelve_week_move": -19.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.202528, "market_dynamics_buy_signal": false, "relative_strength": -30.04753, "fair_value_gap": -31.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "positive", "expectation_probability": 57.5571, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.4% over one week, -5.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "TradingView", "count": 7}, {"label": "Stock Titan", "count": 7}, {"label": "PR Newswire", "count": 5}, {"label": "simplywall.st", "count": 5}, {"label": "Investing.com", "count": 3}, {"label": "The Motley Fool", "count": 2}, {"label": "Insider Monkey", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 55}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 18}, {"label": "Balance sheet", "count": 3}, {"label": "Deals and strategy", "count": 3}, {"label": "Analyst action", "count": 2}, {"label": "Guidance", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "55", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.4% over one week, -5.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "BHC4634780 Bond Profile \u2014 Key Metrics"}], "updated_at": "2026-07-16T07:04:21.428318+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}